期刊文献+

MMP-2和MMP-9在食管癌中表达的研究 被引量:7

Expressions of MMP-2 and MMP-9 in esophageal cancer
原文传递
导出
摘要 目的分析基质金属蛋白酶(MMP)-2和MMP-9在食管癌患者血清中的表达与食管癌临床病理因素之间的关系。方法应用酶联免疫吸附法检测60例食管癌患者血清中MMP-2、MMP-9的含量与患者年龄、性别、组织学类型、临床分期及区域淋巴结转移等临床病理因素之间的关系。结果对照组血清中MMP-2和MMP-9的浓度均值分别为61.31、87.67ng/ml,而食管癌患者血清中MMP-2和MMP-9的浓度均值分别121.66、169.73ng/ml,均高于正常者血清中含量,差异有统计学意义(t=3.015,P=0.007;t=2.037,P=0.04)。MMP-2的含量与有无淋巴结转移(t=2.150,P=0.04)及临床分期(t=2.186,P=0.03)有关,MMP-9的含量与有无淋巴结转移(t=2.390,P=0.02)及临床分期(t=2.149,P=0.03)有关。MMP-2和MMP-9的含量均与食管癌患者的年龄、性别、组织学类型无关(均P〉0.05)。结论MMP-2和MMP-9可能与食管癌的侵袭转移有关。 Objective To analyze the expression levels of matrix metallo proteinase-2 (MMP-2) and matrix metallo proteinase-9 (MMP-9) in sertun of patients with esophageal cancer, and to analyze the interrelations among MMP-2, MMP-9 and clinicopathologic characteristics of esophageal cancer. Methods The levels of serum MMP-2, MMP-9 from 60 patients with esophageal cancer were detected by enzyme linked immunosorbent assay. The interrela- tions among MMP-2, MMP-9 and clinicopathologic characteristics of esophageal cancer including age, gender, histo- logical type, whether or not lymph nodes metastasis and TNM staging were analyzed. Results The levels of MMP-2 and MMP-9 in control group were 61.31 ng/ml and 87.67 ng/ml, the levels of MMP-2 and MMP-9 in patients with esophageal cancer were 121.66 ng/ml and 169.73 ng/ml. The levels of MMP-2 and MMP-9 were significantly higher in patients with esophageal cancer than that of general population (t = 3.015, P = 0. 007 ; t = 2.037, P = 0. 04). The level of MMP-2 was significantly associated with whether or not lymph node metastasis (t = 2. 150, P = 0. 04) and clinical staging (t =2. 186, P=0.03). The level of MMP-9 was significantly associated with whether or not lymph node metastasis (t = 2. 390, P = 0.02) and clinical staging (t = 2. 149, P = 0. 03). The levels of MMP-2 and MMP-9 have no reference to age, gender and histological type (all P 〉 0. 05). Conclusion MMP-2 and MMP-9 may corre- late with tumor invasion and metastasis in patients with esophageal cancer.
出处 《国际肿瘤学杂志》 CAS 2013年第9期708-711,共4页 Journal of International Oncology
关键词 食管肿瘤 基质金属蛋白酶2 基质金属蛋白酶9 Esophageal neoplasms Matrix metalloproteinase 2 Matrix metalloproteinase 9
  • 相关文献

参考文献13

  • 1袁发焕,王海燕,李惊子.ECM,MMPs/TIMPs及其调节研究进展[J].国外医学(生理病理科学与临床分册),2000,20(2):93-96. 被引量:44
  • 2Zeng ZS, Guillem JG. Distinct pattern of matrix metalloproteinase 9and tissue inhibitor of metalloproteinase 1 mRNA expression in humancolorectal cancer and liver metastases. Br J Cancer, 1995, 72 (3):575-582. 被引量:1
  • 3P6rigny M, Bairati I,Harvey I,et al. Role of immunohistochemicaloverexpression of matrix metalloproteinases MMP-2 and MMP-11 inthe prognosis of death by ovarian cancer. Am J Clin Pathol,2008 ,129(2) :226-231. 被引量:1
  • 4Tanioka Y,Yoshida T, Yagawa T, et al. Matrix metalloproteinase-7and matrix metalloproteinase-9 are associated with unfavourable prog-nosis in superficial oesophageal cancer. Br J Cancer, 2003 , 89( 11 ):2116-2121. 被引量:1
  • 5Ohashi K, Nemoto T, Nakamura K, et al. Increased expression ofmatrix metalloproteinase 7 and 9 and membrane type 1 -matrix metallo-proteinase in esophageal squamous cell carcinomas. Cancer,2000,88(10):2201-2209. 被引量:1
  • 6El-Kenawy Ael-M, Lotfy M,El-Kott A, et al. Significance of matrixmetalloproteinase 9 and CD34 expressions in esophageal carcinoma :correlation with DNA content. J Clini Gastroenterol,2005,39 (9 ):791-794. 被引量:1
  • 7Davies B, Waxman J, Wasan H, et al. Levels of matrix metallopro-teases in bladder cancer correlate with tumor grade and invasion.Cancer Res, 1993,53(22) :5365-5369. 被引量:1
  • 8承泽农,于东红,郭冰沁,王萍.食管癌MMP-2表达与p53表达和肿瘤侵袭转移的关系[J].中国肿瘤临床,2004,31(8):471-472. 被引量:4
  • 9于东红,郭冰沁,承泽农,吴礼高,张琼,王萍.食管癌MMP-2表达与肿瘤细胞增殖活性和转移的关系[J].癌变.畸变.突变,2004,16(2):83-85. 被引量:8
  • 10陈荣华,李建生,师晓天.COX-2和MMP-2的表达与食管癌侵袭转移的关系[J].胃肠病学和肝病学杂志,2003,12(2):169-171. 被引量:14

二级参考文献25

  • 1Ji F,Wang WL,Yang ZL,Li YM,Huang HD,Chen WD.Study on the expression of matrix metalloproteinase-2 mRNA in human gastric cancer[J].World Journal of Gastroenterology,1999,5(5):455-457. 被引量:19
  • 2Murata H;Kawano S;Tsuji S;Tsujii M, Sawaoka H, Kimura Y, Shiozaki H, Hori M.Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma,1999. 被引量:3
  • 3Tsujii M;Raymond N;Dubois.Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2[J],1995(03). 被引量:5
  • 4Tsujii M;Kawano S;Dubois RN.Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential[J],1997(07). 被引量:3
  • 5Sier C F;Kubben F J G.Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma,1996(03). 被引量:1
  • 6Ghosh AK;Hirasawa N;Niki H.Cyclooxygenase-2 mediated angiogenesis in carragreenin-induced-granulation tissue in rats,2000(02). 被引量:1
  • 7Liu XH;Kirschenbaum A;Yaos.Inhibition of cyclooxygenase-2 suppress angiogenesis and the growth of prostate cancer in vivo,2000(3Ptl). 被引量:1
  • 8Uefuji K;Ichikura T;Mochizuki H.Cyclooxygenase-2 expression is related to prostaglandin and angiogenesis in human gastric cancer,2000(06). 被引量:1
  • 9Masferrer JL;Koki A;Seibert K.Cox-2 inhibitors, A new class of antiangiogenic agents,1999. 被引量:1
  • 10Poulsom R;Pignatelli M;Stetler-steenson WG.Stromal expression of 72KD type Ⅳ collagenase (MMP-2) and TIMP-2 mRNA in colorectal neolasia,1992(02). 被引量:1

共引文献64

同被引文献59

  • 1Ao R,Du YQ,Wang Y,et al. MMP-2 and DcR3 expres sion in esophageal cancer tissue and correlation with pa tient survival[J]. Int J Clin Exp Med,2013,6(8):700- 705. 被引量:1
  • 2Groblewska M,Mroczko B, Kozlowski M, et al. Serum matrix metalloproteinase 2 and tissue inhibitor of ma- trix metalloproteinases 2 in esophageal cancer patients [J]. Folia Histochem Cytobiol,2012,50(4) :590-598. 被引量:1
  • 3Gnant M, Bartsch R, Steger GG. VHER2-positive breast cancer:a new piece of the puzzle[J]. Lancet Oncol,2014,15(7) :668 669. 被引量:1
  • 4Kwon SH,Jeong SW,Jang JY,et al. Cyclcoxygenase-2 and vascular en dothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma[J]. Clin Mol Hepatol,2012,18(3) :87-94. 被引量:1
  • 5Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and indep endent prognost ic indicat or in early stage breast carcinoma EJ~. J Natl Cancer Inst, 1992,84 (24) : 1875-1887. 被引量:1
  • 6Nakanishi Y, Shiraha H, Nishina S, et al. Loss of runt-related tran scription factor expression leads hepatocellular carcinoma cells to es- cape apoptosis[J3. BMC Cancer, 2011,11 (10) : 3-10. 被引量:1
  • 7Shiau MY, Fan LC, Yang SC, et al. Human papillomavirus up- regulates MMP-2 and MMP 9 expression and activity by indu cing interleukin-8 in lung adenocarcinomas[J]. PLoS One, 2013, 8(1) .- e54423. 被引量:1
  • 8Gurgel DC, Valenca-Junior JT, Dornelas CA, et al. Immunoexpression of metalioproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis[-J~. Pathol On col Res,2015(21) ~73 81. 被引量:1
  • 9Arafiio RF, Lira GA, Vilac JA, et al. Prognostic and diagnostic implications of MMP 2, MMP-9, and VEGF- a expressions in colorectal cancer~J~. Pathol Res Pract,2015,211(15) 171-77. 被引量:1
  • 10Yang G,Zhang Y,Xiong J.Downregulation of Id-1 by small interfering RNA in gastric cancer inhibits cell growth via the Akt pathway[J].Mol Med Report,2012,5(4):1075-1079. 被引量:1

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部